» Authors » Loretta L Jophlin

Loretta L Jophlin

Explore the profile of Loretta L Jophlin including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 14
Citations 93
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Jophlin L, Singal A, Shah V
Am J Gastroenterol . 2024 Sep; 120(3):495-499. PMID: 39264071
No abstract available.
2.
Jophlin L, Singal A, Bataller R, Wong R, Sauer B, Terrault N, et al.
Am J Gastroenterol . 2024 Jan; 119(1):30-54. PMID: 38174913
Alcohol-associated liver disease (ALD) is the most common cause of advanced hepatic disease and frequent indication for liver transplantation worldwide. With harmful alcohol use as the primary risk factor, increasing...
3.
Condon S, Jophlin L
Clin Ther . 2023 Nov; 45(12):1171-1176. PMID: 37980219
Purpose: Alcohol-associated hepatitis (AH) is a unique presentation of cholestatic steatohepatitis with liver dysfunction and malaise preceded by heavy alcohol intake. Although AH exists on a spectrum, in its most...
4.
Groswald A, Gripshover T, Watson W, Wahlang B, Luo J, Jophlin L, et al.
Metabolites . 2023 Aug; 13(8). PMID: 37623845
Many pesticides have been identified as endocrine and metabolism-disrupting chemicals with hepatotoxic effects. However, data are limited for insecticides in the n-methyl carbamate class, including methomyl. Here, we investigate the...
5.
Winrich E, Belur A, Shine A, Jophlin L
Proc (Bayl Univ Med Cent) . 2022 Dec; 36(1):99-100. PMID: 36578602
Takotsubo cardiomyopathy involves transient systolic dysfunction of the left ventricle thought to be caused by a physiologic stress response and associated catecholamine release. We present a previously undocumented cause of...
6.
Sagaram M, Parthasarathy R, Condon S, Closson C, Kong M, Schwandt M, et al.
Int J Mol Sci . 2022 May; 23(10). PMID: 35628661
(1) Background: Fibrosis in early-stage alcohol-associated liver disease (ALD) is commonly under-diagnosed in routine clinical practice. This study characterized the liver-injury and cell death response in alcohol use disorder (AUD)...
7.
Faulkner C, White C, Manatsathit W, Lamb B, Vatsalya V, McClain C, et al.
Alcohol Clin Exp Res . 2022 Feb; 46(4):581-588. PMID: 35102553
Background: Excessive alcohol use is a leading etiology of liver disease and indication for liver transplantation. Accurate measurement of alcohol use remains a challenge in the management of patients in...
8.
Jophlin L, Hartley C, Katzka D
Clin Gastroenterol Hepatol . 2020 Dec; 20(4):e647. PMID: 33279776
No abstract available.
9.
Im G, Mellinger J, Winters A, Aby E, Lominadze Z, Rice J, et al.
Clin Gastroenterol Hepatol . 2020 Oct; 19(11):2407-2416.e8. PMID: 33069880
Background & Aims: While abstinence-promoting behavioral and pharmacotherapies are part of the therapeutic foundation for alcohol use disorder (AUD) and alcohol-associated liver disease (ALD), these therapies, along with alcohol screening...
10.
Manatsathit W, Patel K, Enke T, Sayles H, Jophlin L, Merani S
J Gastrointest Surg . 2020 Oct; 25(8):2026-2034. PMID: 33037558
Background: A higher rate of postoperative morbidity and mortality in patients with portal hypertension from cirrhosis is well recognized; however, the rate of postoperative morbidity and mortality among patients with...